We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current CTLT market cap is 11.45B. The company's latest EPS is USD -5.7462 and P/E is -10.98.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 982M | 1.02B | 1.07B | 1.3B | 1.02B |
| Operating Income | -726M | -112M | -36M | 106M | -84M |
| Net Income | -759M | -206M | -101M | 23M | -129M |
| Year End June 29 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 3.09B | 4B | 4.83B | 4.26B | 4.38B |
| Operating Income | 394.4M | 828M | 755M | -163M | -749M |
| Net Income | 173M | 529M | 503M | -256M | -1.04B |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 10.02B | 9.99B | 9.88B | 9.75B | 9.71B |
| Total Liabilities | 6.18B | 6.3B | 6.27B | 6.15B | 6.17B |
| Total Equity | 3.84B | 3.69B | 3.61B | 3.6B | 3.54B |
| Year End June 29 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 7.78B | 9.11B | 10.51B | 10.78B | 9.75B |
| Total Liabilities | 4.27B | 4.84B | 5.71B | 6.17B | 6.15B |
| Total Equity | 2.9B | 3.92B | 4.8B | 4.61B | 3.6B |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -70M | 42M | 54M | 268M | 61M |
| Investing | -84M | -179M | -253M | -327M | -34M |
| Financing | 98M | 84M | 84M | 74M | -10M |
| Year End June 29 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 440.3M | 433M | 439M | 254M | 268M |
| Investing | -827.5M | -649M | -1.88B | -955M | -327M |
| Financing | 1B | 142M | 1.03B | 521M | 74M |
| Market Cap | 11.45B |
| Price to Earnings Ratio | -10.98 |
| Price to Sales Ratio | 2.61 |
| Price to Cash Ratio | 39.61 |
| Price to Book Ratio | 3.18 |
| Dividend Yield | - |
| Shares Outstanding | 181.51M |
| Average Volume (1 week) | 3.48M |
| Average Volume (1 Month) | 2.5M |
| 52 Week Change | 69.09% |
| 52 Week High | 63.25 |
| 52 Week Low | 37.03 |
| Spread (Intraday) | 0.98 (1.54%) |
| Company Name | Catalent Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.catalent.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
